Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

被引：60
|
作者：
Boissinot, Marjorie [1 ]
Lippert, Eric [1 ]
Girodon, Francois [1 ]
Dobo, Irene [1 ]
Fouassier, Marc [1 ]
Masliah, Claude [1 ]
Praloran, Vincent [1 ]
Hermouet, Sylvie [1 ]
机构：
[1] CHU Nantes, Lab Hematol, Inst Biol, F-44093 Nantes, France
来源：
BLOOD | 2006年 / 108卷 / 09期
关键词：
D O I：
10.1182/blood-2006-05-021527
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3223 / 3224
页数：2
相关论文
共 50 条
  • [11] The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis
    Goodyer, Matthew
    Langabeer, Stephen E.
    Haslam, Karl
    Murphy, Karen
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (01) : 229 - 230
  • [12] Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis
    De Moner, Blanca
    Martinez-Sanchez, Julia
    Garrote, Marta
    Ramos, Alex
    Ventosa-Capell, Helena
    Moreno-Castano, Ana
    Nomdedeu, Meritxell
    Ojeda, Asuncion
    Escolar, Gines
    Garcia-Pagan, Joan Carles
    Arellano-Rodrigo, Eduardo
    Carreras, Enric
    Alvarez-Larran, Alberto
    Diaz-Ricart, Maribel
    THROMBOSIS AND HAEMOSTASIS, 2025,
  • [13] JAK2-V617F mutation in cerebral venous thrombosis
    Koopman, K.
    Mulder, A. B.
    De Keyser, J.
    Luijckx, G. J.
    van der Meer, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (06) : 1039 - 1040
  • [14] Prevalence of the JAK2-V617F mutation in Taiwanese patients with chronic myeloproliferative disorders
    Lieu, C. -H.
    Wu, H. -S.
    Hon, Y. -C.
    Tsai, W. -H.
    Yang, C. -F.
    Wang, C. -C.
    Lin, Y. -C.
    Shih, C. -H.
    Hsu, H. -C.
    INTERNAL MEDICINE JOURNAL, 2008, 38 (6A) : 422 - 426
  • [15] Myeloid blasts in transformed JAK2-V617F positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.
    Theocharides, Alexandre
    Boissinot, Marjorie
    Garand, Richard
    Girodon, Francois
    Teo, Soon-Siong
    Lippert, Eric
    Tichelli, Andre
    Hermouet, Sylvie
    Skoda, Radek C.
    BLOOD, 2006, 108 (11) : 115A - 115A
  • [16] THE ROLE OF JAK2-V617F MUTATION IN LEUKEMIC TRANSFORMATION OF MYELOPROLIFERATIVE NEOPLASMS
    Tevet, M.
    Lupu, A.
    Saguna, C.
    Dragan, C.
    Colita, A.
    Barca, G.
    HAEMATOLOGICA, 2012, 97 : 633 - 633
  • [17] The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
    Ipek Yonal
    Binnur Pinarbası
    Fehmi Hindilerden
    Veysel Sabri Hancer
    Meliha Nalcaci
    Sabahattin Kaymakoglu
    Reyhan Diz-Kucukkaya
    Journal of Thrombosis and Thrombolysis, 2012, 34 : 388 - 396
  • [18] The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
    Yonal, Ipek
    Pinarbasi, Binnur
    Hindilerden, Fehmi
    Hancer, Veysel Sabri
    Nalcaci, Meliha
    Kaymakoglu, Sabahattin
    Diz-Kucukkaya, Reyhan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) : 388 - 396
  • [19] Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders
    Speletas, Matthaios
    Katodritou, Eirini
    Daiou, Chrisoula
    Mandala, Eudokia
    Papadakis, Emmanouil
    Kioumi, Anna
    Ritis, Konstantinos
    Korantzis, Ioannis
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1053 - 1062
  • [20] JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders
    Owens, Christopher D.
    JOURNAL OF VASCULAR SURGERY, 2010, 52 (01) : 205 - 207
12345